Corona Pharmaceuticals Private Limited. - Company Profile

It is a healthcare private limited company based in Kashipur, Uttarakhand, India, established in 2008.
2008 Kashipur, Uttarakhand, India Active
Last Updated:
Access Report
About Corona Pharmaceuticals Private Limited.

Corona Pharmaceuticals Private Limited., a active private limited company, was established on 24 September 2008 in Kashipur, Uttarakhand, India. Engaging in preventive health services within the trade sector, it holds CIN: U85100UR2008PTC032700. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹1.30 Cr and a paid-up capital of ₹7.67 M.

It upholds a compliant status. Employing 53 professional, Its leadership includes Satanshu Mathur (Director), Babita Dixit (Additional Director), Vivek Khandelwal (Director). Past directors included Suraj Arora, Pramod Kumar, Babita Dixit. It holds ₹2.14 Cr open charges and ₹9.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 7Th Milestone Jaspur Roas Kunda Crossing, Kashipur, Uttarakhand, 244713.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100UR2008PTC032700

  • Registration Number

    032700

  • Incorporation Date

    24 September 2008

  • Authorized Capital

    ₹1.30 Cr

  • Paid-Up Capital

    ₹7.67 M

  • ROC Code

    Roc Uttarakhand

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.30 Cr
  • Paid Up Capital ₹ 7.67 M
  • Company Age 17 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.14 Cr
  • Satisfied Charges ₹ 9.50 M
  • Revenue Growth **** 7.12%
  • Profit Growth **** 142.36%
  • Ebitda **** 6.24%
  • Net Worth 148.82%
  • Total Assets **** 7.28%
Company report

Corona Pharmaceuticals Private Limited.

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Corona Pharmaceuticals Private Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Corona Pharmaceuticals Private Limited.?
Current Directors
Name Designation Appointment Date Status
Satanshu Mathur Director 10 Dec 2008 Current
Babita Dixit Additional Director 01 Apr 2021 Current
Vivek Khandelwal Director 31 Jul 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Dec 2008 Past
Pramod Abcsdd Director 10 Dec 2008 Past
Pramod Abcsdd Director 27 Aug 2018 Past
Pramod Abcsdd Additional Director 09 Apr 2021 Past
Pramod Abcsdd Director 27 Aug 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Corona Pharmaceuticals.

Corona Pharmaceuticals Private Limited., for the financial year ended 2024, experienced modest growth in revenue, with a 7.12% increase. The company also saw a substantial improvement in profitability, with a 142.36% increase in profit. The company's net worth Soared by an impressive increase of 148.82%.

Corona Pharmaceuticals revenue growth over time
Corona Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 7.12%
*******
*******
*******
*******
Revenue from Operations
*******
 6.49%
*******
*******
*******
*******
Total Assets
*******
 7.28%
*******
*******
*******
*******
Profit or Loss
*******
 142.36%
*******
*******
*******
*******
Net Worth
*******
 148.82%
*******
*******
*******
*******
EBITDA
*******
 6.24%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Corona Pharmaceuticals?

In 2024, Corona Pharmaceuticals had a promoter holding of 24.20% and a public holding of 75.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹21,400,000.00

Satisfied Charges

₹9,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 2.14 Cr
Latest Charge Details
Date Lender Amount Status
14 Aug 2023 Others ₹1.40 M Open
30 Jun 2022 Others ₹2.00 Cr Open
06 Jul 2018 Others ₹9.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Corona Pharmaceuticals?

Corona Pharmaceuticals has a workforce of 53 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Corona Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corona Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Corona Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Corona Pharmaceuticals Private Limited. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Corona Pharmaceuticals Private Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.14 Cr with Charge ID 100770694 was registered on 14 Aug 2023. was documented.

  • Director Appointment

    The activity Vivek Khandelwal was appointed as a Director was appointed as a Director on 31 Jul 2023 & has been associated with this company since 2 years 7 months . was completed.

  • Charges

    Progress on A charge registered on 06 Jul 2018 via Charge ID 100190772 with Others was fully satisfied on 15 Jul 2022. was documented.

  • Charges

    A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100593888 was registered on 30 Jun 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Corona Pharmaceuticals Private Limited.?

The CIN of Corona Pharmaceuticals Private Limited. is U85100UR2008PTC032700.

Where is Corona Pharmaceuticals Private Limited. headquartered?

Corona Pharmaceuticals Private Limited. is headquartered at 7Th Milestone Jaspur Roas Kunda Crossing, Kashipur, Uttarakhand, 244713.

When was Corona Pharmaceuticals Private Limited. incorporated?

Corona Pharmaceuticals Private Limited. was incorporated on 24 September 2008.

Who are the current directors of Corona Pharmaceuticals Private Limited.?

The current directors of Corona Pharmaceuticals Private Limited. are

What is the primary industry of Corona Pharmaceuticals Private Limited.?

The primary industry of Corona Pharmaceuticals Private Limited. is Trade.

Is Corona Pharmaceuticals Private Limited. a listed company?

Corona Pharmaceuticals Private Limited. is unlisted.

What is the capital structure of Corona Pharmaceuticals Private Limited.?

The authorized capital of Corona Pharmaceuticals Private Limited. is ₹1.30 Cr, and the paid-up capital is ₹7.67 M.

What is the compliance status of Corona Pharmaceuticals Private Limited.?

The compliance status of Corona Pharmaceuticals Private Limited. is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available